Review of preclinical data on hyperthermia treatment in lymphomas and its potential for clinical application
Introduction Hyperthermia (HT) at temperatures between 39 °C and 44 °C is utilized as an adjunctive cancer therapy, serving as potent radio- and chemosensitizer. Its effectiveness in treating solid malignancies has been well established. This raises the question of whether HT can also benefit patien...
Saved in:
Main Authors: | Moritz V. Scharr, Frederik Damm, Paul Krahl, Anna Dieper, Paraskevi D. Veltsista, Alexander Hansch, Marcus Beck, Dominik Gerster, Anna-Chiara Giovannelli, Lars Bullinger, Daniel Zips, Pirus Ghadjar |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | International Journal of Hyperthermia |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/02656736.2024.2418427 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparisons of computer simulations and experimental data for capacitive hyperthermia using different split-phantoms
by: Rami Muratoglu, et al.
Published: (2024-12-01) -
Literature review: potential non-thermal molecular effects of external radiofrequency electromagnetic fields on cancer
by: Anna Dieper, et al.
Published: (2024-12-01) -
Regional hyperthermia for soft tissue sarcoma – a survey on current practice, controversies and consensus among 12 European centers
by: Siyer Roohani, et al.
Published: (2024-12-01) -
Alternating magnetic field guiding system for MNP hyperthermia treatment of deep-seated cancers
by: Robert V. Stigliano, et al.
Published: (2024-12-01) -
Toward enhanced quality assurance guidelines for deep hyperthermia devices: a multi-institution study
by: Mattia De Lazzari, et al.
Published: (2024-12-01)